How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy | Zendy

Nicoletta Bernardini | Zendy; Nevena Skroza | Zendy; Alessandra Spagnoli | Zendy; Anna Marchesiello | Zendy; Veronica Balduzzi | Zendy; Ersilia Tolino | Zendy; Alessandra Mambrin | Zendy; Simone Michelini | Zendy; Patrizia Maddalena | Zendy; Salvatore Volpe | Zendy; Ilaria Proietti | Zendy; Annarita Vestri | Zendy; Concetta Potenza | Zendy

Open Access

How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy

Author(s) -

Nicoletta Bernardini,

Nevena Skroza,

Alessandra Spagnoli,

Anna Marchesiello,

Veronica Balduzzi,

Ersilia Tolino,

Alessandra Mambrin,

Simone Michelini,

Patrizia Maddalena,

Salvatore Volpe,

Ilaria Proietti,

Annarita Vestri,

Concetta Potenza

Publication year - 2021

Publication title -

journal of infection and public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.983

H-Index - 35

eISSN - 1876-035X

pISSN - 1876-0341

DOI - 10.1016/j.jiph.2021.03.010

Subject(s) - medicine , psoriasis , pandemic , observational study , population , disease , covid-19 , quality of life (healthcare) , emergency medicine , environmental health , immunology , infectious disease (medical specialty) , nursing

The outbreak of coronavirus disease-2019 (COVID-19) is a public health crisis of global proportion. In psoriatic patients treated with biologic agents, evidence is not yet available on susceptibility to infection with the novel SARS-CoV-2 coronavirus, and data about the perception of COVID-19 and its impact on these patients are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research